Express News | USA President Biden: Novo-Nordisk must reduce the price of Ozempic (injectable anti-diabetic drug) and Wegovy (injectable weight loss drug).

Breakings19:58

US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices

Eli Lilly (LLY.SW) and Novo Nordisk (NOVO-B.CO) were singled out by US President Joe Biden for "price gouging" and "corporate greed" for the prices of their diabetes and obesity drugs in the country.

MT Newswires57minutes ago

US stock market anomaly | Biden claims it "deceived the American people", Eli Lilly and Co (LLY.US) and Novo Nordisk A/S (NVO.US) fell more than 3%.

According to Zhītōng Cáijīng APP, on Tuesday, the stock prices of US pharmaceutical companies Eli Lilly and Co. (LLY.US) and Novo Nordisk A/S (NVO.US) fell, both dropping more than 3% at the time of writing. Previously, US President Biden urged these two pharmaceutical giants to significantly reduce the prices of their products, including anti-obesity drugs. In an article published by foreign media, Biden and Senator Sanders stated that Eli Lilly and Novo Nordisk are examples of large pharmaceutical companies "cheating the American people." Biden and Sanders stated, "If these drugs are not significantly reduced in price, they could potentially bankrupt America's healthcare system. We will not allow that."

Zhitong Finance22:03

Benzinga Market Summary: Powell Speaks At ECB, Tesla Surges On Delivery Figures, Biden Admin Launches US Chip Workforce Program, Novo Nordisk Falls After Biden Urges Ozempic Price Cut

Benzinga Market Summary: Powell Speaks At ECB, Tesla Surges On Delivery Figures, Biden Admin Launches US Chip Workforce Program, Novo Nordisk Falls After Biden Urges Ozempic Price Cut

Benzinga21:46

Express News | The three major US stock indexes collectively opened low, with the Dow falling 0.20%, the Nasdaq falling 0.40%, and the S&P 500 index falling 0.30%. Tesla rose more than 4%, with second-quarter deliveries of 443,956 vehicles exceeding market expectations.

Breakings21:30

U.S. FDA Sends Warning Letter To Ozempen.com; FDA Observed That Introduces Into Interstate Commerce Unapproved And Misbranded Semaglutide Drug Products; Requests Cease Offering Any Unapproved And Misbranded Drugs For Sale To U.S. Consumers

U.S. FDA Sends Warning Letter To Ozempen.com; FDA Observed That Introduces Into Interstate Commerce Unapproved And Misbranded Semaglutide Drug Products; Requests Cease Offering Any Unapproved And Misb

Benzinga21:24